Journal Of Clinical Oncology (jco) Podcast
Dexamethasone and High-Dose Methotrexate in High-Risk B Cell Acute Lymphoblastic Leukemia—Where Should We Go From Here?
- Author: Vários
- Narrator: Vários
- Publisher: Podcast
- Duration: 0:10:32
- More information
Informações:
Synopsis
The Children's Oncology Group study led by Larsen et al. showed that children and young adult patients with high-risk B cell acute lymphoblastic leukemia benefit from receiving high-dose methotrexate during interim maintenance 1 and that those aged 1 to 9 years benefit from receiving dexamethasone for 14 days during induction.
